Cediranib (recentin, AZD2171) reverses ABCB1- and ABCC1-mediated multidrug resistance by inhibition of their transport function

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, March 2009

Altmetric Badge

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 48 Dimensions

Readers on

mendeley: 36 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Method for diagnosing or prediagnosing a beta-amyloidopathy or an alpha-synucleopathy

Grant US-9370523-B2

United States of America